Hong Kong · Delayed Price · Currency is HKD Ocumension Therapeutics Statistics
Total Valuation
HKG:1477 has a market cap or net worth of HKD 4.15 billion. The enterprise value is 3.87 billion.
| Market Cap | 4.15B |
| Enterprise Value | 3.87B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1477 has 815.38 million shares outstanding. The number of shares has increased by 6.09% in one year.
| Current Share Class | 815.38M |
| Shares Outstanding | 815.38M |
| Shares Change (YoY) | +6.09% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 14.49% |
| Owned by Institutions (%) | 6.46% |
| Float | 353.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.97 |
| PS Ratio | 3.85 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.59 |
| EV / EBITDA | 134.83 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.31 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 11.60 |
| Debt / FCF | -5.59 |
| Interest Coverage | -27.66 |
Financial Efficiency
Return on equity (ROE) is -3.45% and return on invested capital (ROIC) is -2.03%.
| Return on Equity (ROE) | -3.45% |
| Return on Assets (ROA) | -1.93% |
| Return on Invested Capital (ROIC) | -2.03% |
| Return on Capital Employed (ROCE) | -3.22% |
| Weighted Average Cost of Capital (WACC) | 6.22% |
| Revenue Per Employee | 1.77M |
| Profits Per Employee | -238,330 |
| Employee Count | 608 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 7.74 |
Taxes
In the past 12 months, HKG:1477 has paid 836,992 in taxes.
| Income Tax | 836,992 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.88% in the last 52 weeks. The beta is 0.43, so HKG:1477's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -38.88% |
| 50-Day Moving Average | 5.28 |
| 200-Day Moving Average | 6.44 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 390,702 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1477 had revenue of HKD 1.08 billion and -144.90 million in losses. Loss per share was -0.18.
| Revenue | 1.08B |
| Gross Profit | 508.87M |
| Operating Income | -143.12M |
| Pretax Income | -144.07M |
| Net Income | -144.90M |
| EBITDA | 15.70M |
| EBIT | -143.12M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 605.28 million in cash and 333.18 million in debt, with a net cash position of 272.10 million or 0.33 per share.
| Cash & Cash Equivalents | 605.28M |
| Total Debt | 333.18M |
| Net Cash | 272.10M |
| Net Cash Per Share | 0.33 |
| Equity (Book Value) | 4.18B |
| Book Value Per Share | 5.13 |
| Working Capital | 744.24M |
Cash Flow
In the last 12 months, operating cash flow was -16.79 million and capital expenditures -42.78 million, giving a free cash flow of -59.57 million.
| Operating Cash Flow | -16.79M |
| Capital Expenditures | -42.78M |
| Depreciation & Amortization | 160.98M |
| Net Borrowing | 241.07M |
| Free Cash Flow | -59.57M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 47.19%, with operating and profit margins of -13.27% and -13.44%.
| Gross Margin | 47.19% |
| Operating Margin | -13.27% |
| Pretax Margin | -13.36% |
| Profit Margin | -13.44% |
| EBITDA Margin | 1.46% |
| EBIT Margin | -13.27% |
| FCF Margin | n/a |
Dividends & Yields
HKG:1477 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.09% |
| Shareholder Yield | -6.09% |
| Earnings Yield | -3.49% |
| FCF Yield | -1.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:1477 is 9.17, which is 80.33% higher than the current price. The consensus rating is "Buy".
| Price Target | 9.17 |
| Price Target Difference | 80.33% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 35.46% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1477 has an Altman Z-Score of 5.56 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.56 |
| Piotroski F-Score | 3 |